<DOC>
	<DOC>NCT02529865</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of periurethral injection of autologous Adipose Derived Regenerative Cells (ADRCs) in male stress urinary incontinence.</brief_summary>
	<brief_title>Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence, Stress</mesh_term>
	<criteria>Males with stress urinary incontinence with insufficient effect by behavioral therapy or pharmacotherapy persisting more than 1 year after either of the following surgical procedure: Patients with symptoms after radical prostatectomy for localized prostate cancer and currently without relapse/metastasis, and PSA level less than 0.1 ng/mL for over 1 year Patients with symptoms after transurethral prostatectomy or laser prostatectomy for prostatic hyperplasia, and PSA level less than 4.0 ng/mL over 1 year Age of 20 or above Mild to moderate urinary incontinence on the 24hour pad test Patients who can keep a bladder diary in a satisfactory manner Patients who are willing and able to give signed consent Concurrent with any other types of urinary incontinence History of urinary or reproductive surgery within 6 months History of behavioral therapy or pharmacotherapy within 3 months Concurrent with diabetes insipidus History of radiotherapy in the lower urinary tract History of ADRCs treatment for stress urinary incontinence History of any type of cell therapy within 6 months Participation in any other clinical trial within 3 months Concurrent with lower urinary tract obstruction Concurrent with urolithiasis, urinary tract infection or interstitial cystitis History of recurrent urinary tract infection History of malignant neoplasm within 5 years or a suspicion of it Life expectancy of less than 1 year Any other patients whom the trial investigator deemed ineligible to this study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cell Transplantation</keyword>
</DOC>